Shang Hai Zheng Quan Bao·2026-01-12 12:42Core Viewpoint - Alibaba Health's stock price increased by 8.32% to HKD 6.25 per share as of January 12, 2023, indicating positive market sentiment towards the company [1]. Group 1: Stock Performance - As of 1:53 PM on January 12, Alibaba Health's stock rose by 8.32%, reaching a price of HKD 6.25 per share [1]. - The stock opened at HKD 6.25, with a low of HKD 6.28 and a high of HKD 5.83 during the trading session [3]. - The trading volume was 203 million shares, with a turnover of HKD 1.26 billion [3]. Group 2: Strategic Partnership - On January 8, Alibaba Health announced a strategic partnership with Beijing Meiersen Pharmaceutical Technology Development Co., Ltd. to collaborate in the field of innovative drugs for pediatric specialties [6]. - The partnership will focus on the global launch of the first approved topical innovative drug for treating infantile hemangiomas, named Beimeijing® (Timolol Maleate Gel) [6]. - This collaboration aims to enhance patient education, public welfare assistance, and multi-channel launch strategies, marking a significant breakthrough in the development of pediatric-specific medications in China [6].